CBOE vs RNAC · P/E 24, rev $2.72B vs P/E 2.1, rev $78.0K
Cboe Global Markets Inc (CBOE) versus Cartesian Therapeutics Inc. (RNAC) — a side-by-side from cached financials, not a winner call.
Cboe Global Markets Inc (CBOE) is a financial data & stock exchanges company listed on US.
Cartesian Therapeutics Inc. (RNAC) is a biotechnology company listed on US.
Latest reported CBOE revenue for 2026-06-30 was $2.72B. Net income was $738.8M. CBOE currently screens at market cap $29.50B and trailing P/E 24.1.
Latest reported RNAC revenue for 2026-06-30 was $78.0K. Net income was -$23.4M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. RNAC currently screens at market cap $290.9M and trailing P/E 2.1.
CBOE currently screens at market cap $29.50B and trailing P/E 24.1. RNAC currently screens at market cap $290.9M and trailing P/E 2.1.
Not investment advice. Open the CBOE and RNAC stock pages for the full models.
Not investment advice.